InvestorsHub Logo
Followers 28
Posts 4372
Boards Moderated 1
Alias Born 09/22/2006

Re: biotechinvestor1 post# 8225

Thursday, 02/15/2024 3:47:50 PM

Thursday, February 15, 2024 3:47:50 PM

Post# of 8686
Catalent is a CDMO, i.e., Novo bought them out to gain additional drug manufacturing capacity to meet the surging demand for the semaglutide products. I don't know how much the syringe part of Catalent played a role in the deal, if any at all.

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News